Zacks Investment Research
18 Nov 2026, 01:26 UTC · 56m ago
UnitedHealth (UNH) vs. Humana (HUM): Buy the Dip?
Impact · against what's priced in
Proposed Medicare Advantage regulations creating a $9 billion industry-wide headwind represent a material new risk to revenue that is not accounted for in current valuations. While both companies raised EPS guidance, these updates are largely absorbed by the market, leaving the regulatory news as the primary negative catalyst.
- HUM−0.60
Not in the price yet
- The price assumes
A 3% sustainable pretax margin by 2028
The proposed recovery of $9 billion in improper payments across the industry threatens the revenue base and complicates Humana's path toward its targeted 3% sustainable pretax margin by 2028.
What HUM's price assumes · Sep 1

Search tags




